AstraZeneca PLC - Total Other Income Expense Net

AstraZeneca PLC's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Total-Other-Income-Expense-Net" stands at -1.33 Billion United States Dollars for the trailing twelve months (TTM) period ending 06/30/2026.

AstraZeneca PLC's second quarter result of -0.3111 Billion USD for the item "Total Other Income Expense Net" represents an increase of 6.29 percent compared to it's first quarter result.

Also, AstraZeneca PLC's second quarter result of -0.3111 Billion USD for the item "Total Other Income Expense Net" represents a decrease of -5.21 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), AstraZeneca PLC's second quarter result of -1.33 Billion USD for the item "Total Other Income Expense Net" represents a decrease of -1.17 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 0.312 Billion United States Dollars compared to the value the year prior.
The 1 year change is 0.312 Billion United States Dollars.
The 3 year change is -0.7437 Billion United States Dollars.
The 5 year change is -0.2325 Billion United States Dollars.
The 10 year change is -0.1581 Billion United States Dollars.

The Serie's long term average value is -1.17 Billion United States Dollars. It's latest available value, on 06/30/2026, is -0.157 Billion United States Dollars lower, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 06/30/2022, to it's latest available value, on 06/30/2026, is +2.27 Billion.
The Serie's change in United States Dollars from it's maximum value, on 03/31/2018, to it's latest available value, on 06/30/2026, is -1.36 Billion.